GlobeImmune (United States)
GlobeImmune, Inc. is a clinical-stage public biopharmaceutical company headquartered in Louisville, Colorado, that develops therapeutic vaccines to treat cancer and infectious diseases. As of August 2014, the company had no marketed products. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for GlobeImmune (United States), United States, covering academic research published from 2002 to 2020. Read More.
Open Access Percentage
35%
Total
Publications
55
Total Open
Publications
19
Total
Citations
3.3K
Open Access
Percentage
35%
Total
Publications
55
Total Open
Publications
19
Total
Citations
3.3K
Breakdown
Publisher Open
16%
Both
19%
Other Platform Open
3%
Closed
62%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 40%
8
Hybrid 25%
5
No Guarantees 35%
7
Other Platform Open
Other Internet 46%
6
Domain 38%
5
Institution 15%
2
Public 8%
1
Preprint 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
DOI | Other Internet | 6 |
PubMed Central | Domain | 5 |
Yonsei University Medical Library - YUHSpace | Institution | 1 |
University of Modena and Reggio Emilia - IRIS UNIMORE | Institution | 1 |
Figshare | Public | 1 |
Europe PMC | Domain | 1 |
Erasmus University, Rotterdam - RePub | Institution | 1 |
DANS - Data Archiving and Networked Services | Institution | 1 |